article thumbnail

DEBRA Research, LEO Pharma Partner to Advance Treatments for EB

The Dermatology Digest

We are pleased to announce our non-exclusive partnership with LEO Pharma, which has demonstrated a strong track record in developing medicines for hard-to-treat skin conditions, saysProf.Hubert Truebel, MD, MBA, Managing Director at DEBRA Research, in a news release. There are currently no approved treatment options for EB.

article thumbnail

Candela Launches Vbeam Pro Laser Platform for Vascular and Dermatologic Conditions

The Dermatology Digest

. “Building on Candela’s longstanding clinical leadership, the introduction of the Vbeam Pro system represents a major leap forward in the treatment of vascular and other skin conditions,” addsGeoffrey Crouse, Chief Executive Officer of Candela.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Biosimilar News: Selarsdi Scores FDA Approval for Interchangeability With Stelara

The Dermatology Digest

patients to more affordable treatment options and contribute to lowering healthcare costs, which is an important part of our mission as a leading developer and manufacturer of biosimilars globally, adds Anil Okay, Chief Commercial Officer for Alvotech. With two important biosimilars on the U.S. With two important biosimilars on the U.S.

article thumbnail

L’Oreal to Buy 10% Stake in Galderma

The Dermatology Digest

The two companies are also teaming up for a new a scientific partnership focused on complementary research projects. “We We look forward to pursuing scientific partnership opportunities together, for the benefit of the customers, patients and consumers we serve across the globe every day.” “I

article thumbnail

Done Deal: Organon Completes Acquisition of Dermavant

The Dermatology Digest

“The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.

article thumbnail

New Tox in Town: LetibotulinumtoxinA-wlbg (Letybo, Hugel & Benev) Now Fully Commercialized in the U.S.

The Dermatology Digest

market,” says Ethan Min, Chief Executive Officer at BENEV, in a news release. “This partnership with Hugel allows us to strengthen our market position and fulfill our mission to BENefit EVeryone through transformative aesthetic solutions.” “We are honored to join forces with Hugel to bring Letybo to the U.S.

article thumbnail

7 Ways We’re An Eco-Friendly Business 

Eminence Organics

From our green office space in Vancouver, Canada to our sustainable farming practices in Hungary, being green is at the heart of what we do. Eminence Organics, in partnership with Trees For The Future , plants a tree for every retail skin care product sold, allowing us to support communities in developing countries.

Office 105